Profile
Mark Genovese is currently the Senior Vice President-Immunology Development at Eli Lilly & Co. He previously worked as the Director at Kyverna Therapeutics, Inc. and as the Clinical Chief-Immunology & Rheumatology at Stanford University.
From 2020 to 2023, he served as the Senior Vice President-Inflammation Development at Gilead Sciences, Inc. Dr. Genovese completed his undergraduate degree at the University of Notre Dame and obtained his doctorate from The Johns Hopkins University School of Medicine.
Mark Genovese active positions
| Companies | Position | Start |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 16/10/2023 |
Former positions of Mark Genovese
| Companies | Position | End |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/09/2023 |
| KYVERNA THERAPEUTICS, INC. | Director/Board Member | - |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Training of Mark Genovese
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
University of Notre Dame
University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University School of Medicine
The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kyverna Therapeutics, Inc.
Kyverna Therapeutics, Inc. BiotechnologyHealth Technology Operates as a cell therapy company which develops treatments and potential cures for serious autoimmune diseases | Health Technology |
- Stock Market
- Insiders
- Mark Genovese
















